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left ventricular ejection fraction (LVEF), valve prosthesis type and
position of valve, chordal preservation surgery, atrial ﬁbrillation
(AF), left atrial (LA) size] as predictor to PHVT and the outcome of
management by thrombolysis. In the current study, we intend to
evaluate whether AF is an independent predictor of PHVT.
Methods:Weprospectively collected data of all patients presenting
to our out-patient, in-patient and emergency room of department
of cardiology. All baseline parameters (demographic characteris-
tics, compliance to OAC, LVEF, valve prosthesis type and position
of valve, AF and LA size) were noted and were subjected to uni-
variate and multivariate analysis to determine their association to
PHVT.
Results: Since June 2013 to June 2015, 33 patients (20 female,
13male) with PHVT were admitted to our department. Baseline
characteristics are shown in Table 1.
Mean age of patients presenting with PHVTwas 39  12 years, with
females accounting for 2/3rd of the all PHVT patients. A total of 36
valves were thrombosed in 33 patients. Mitral valvewas affected in
28 patients and 8 patients had thrombosis of aortic valve. Mean
time duration after valve replacement till presentation with PHVT
was 4 (range 4–240)months. Mean LA diameter at was 44  16 mm.
24 (72%) of patients were in AF and overall the LVEF was almost
normal in all patients. Only 9 (25%) of patients were compliant to
the OAC prescribed.
Overall themost predominant cause of PHVT is non-compliance to
OAC.
Conclusion: Because of the inadequate number of patients with
PHVT, multivariate analysis could not be done to determine the
signiﬁcance of association of risk factors to PHVT. Overall non-
compliance to OAC appears to be the most important cause of
PHVT. AF in association is found in 72% of patients.
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Background: Stroke is a serious complication of atrial ﬁbrillation
(AF) and oral anticoagulants are effective in reducing the risk of
stroke. New oral anticoagulants (NOAC's) are available now as
alternatives.
Aims: (1) To study the clinical proﬁle of patients with AF and
attendant problems, (2) to assess the risk of stroke and bleeding
in patients with non valvar AF (NVAF) and (3) to study the fre-
quency of usage of vitamin K antagonists (VKA) and NOACs and
their attendant problems.
Methods: All consecutively hospitalized patients with AF and
those patients with AF seen in cardiology OPD were included in
this observational prospective registry study. CHA2DS2-VASc and
HASBLED scores were applied in patients with NVAF. Renal func-
tion was assessed by Cockroft–Gault formula.
Results: Of 106 patients, 56 (52.83%) were males and 50 (47.17%)
were females. The mean age was 64.67 years. 31 (29.24%) patients
had valvar AF, and 75 (70.76%) NVAF. 16 (15.09%) patients had
stroke. 51 (48.11%) had hypertension, 23 (21.69%) had diabetes, 21
(19.81%) had coronary artery disease, 5 (4.71%) had cardiomyopa-
thy, 18 (16.9%) were detected to have thyroid dysfunction and 7
(6.6%) chronic kidney disease.
The mean CHA2DS2-VASc score was 3.54, and HASBLED score was
2.11. Of 31 patients of valvar AF, 27 received VKA and 4 patients
took no anticoagulants. Out of 75 patients with NVAF, 17 received
NOAC, 29were onVKA (26 refusedNOACdue to cost constraint and
3 had creatinine clearance <30 ml/min) and 29 on antiplatelets
(CHADS score 1 or less in 5 and 24 unwilling to take anticoagulant).
3 switched to NOAC fromVKA, and 1 opted to switch fromNOAC to
VKA. Of 56 patients who were on VKA, 4 had hemorrhagic stroke. 6
patients died. No siginiﬁcant adverse effects were reported with
NOACs except one patient developed hematuria. VKA were asso-
ciated with increase risk of hemorrhagic stroke.
Conclusion:
1. NVAF was more frequent than valvar AF.
2. Antiplatelets are still being used inappropriately.
3. NOACs are attractive alternatives to VKA, but are expensive.
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The combination of ventricular tachycardia (VT) and severe left
ventricular dysfunction presents a serious challenge in manage-
ment of acute fulminant myocarditis (AFM). We present a case of a
52-year-old male with AFM, who presented with hypotension and
incessant VT not responsive to pharmacological therapy. He
underwent successful catheter ablation.
Introduction:Myocarditis is clinically and pathologically deﬁned as
‘‘inﬂammation of the myocardium’’. Clinical presentations of the
disease range from nonspeciﬁc systemic symptoms (fever, myal-
gias, palpitations, or exertional dyspnea) to fulminant hemody-
namic collapse and sudden death. Furthermore, it has been
identiﬁed as a cause of dilated cardiomyopathy in 9% of cases in
a large prospective series. Endomyocardial biopsy and autopsy
ﬁndings have clearly demonstrated that myocarditis represents
a frequent cause of life-threatening ventricular arrhythmias and
sudden death.
Electroanatomic mapping allows operators to record intracardiac
electrical activation in relation to anatomic location in a cardiac
chamber of interest, even during arrhythmia mapping. Although
use of electrophysiological ablation in AFM has not been docu-
mented widely, in exceptional cases where VT is not responding to
conventional treatment ablation remains a useful alternative.
Case:A 52-year-oldmale known case of hypertension and diabetes
mellitus since last 10 years had a history of traveling in last 15 days
following which he started experiencing fever and breathlessness.
Further, he developed swelling over his feet, abdomen and face for
which he admitted in a private hospital where he was managed
medically. But his condition went on deteriorating and he had
incessant VT for which he was given around 20 DC shock and was
intubation and IABP was inserted. 2D Echo was done which
showed global LV hypokinesia with ejection fraction of 25–30%.
He was diagnosed to be suffering from viral myocarditis and was
Table 1
Baseline characteristics n = 33
Age (mean  SD), years 39  12
Sex (M:F) 20:13
Valve at mitral position 28
Valve at aortic position 8
Time duration since valve replacement
(months, range)
34 (4–240)
LA diameter in mm (mean  SD) 44  16
Patients with AF [n (%)] 24 (72%)
LVEF (%) 58  6%
Compliance to OAC, n (%) 6 (25%)
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started on cardarone infusion and other supportive measures. But
his liver function went abnormal and so he was put on xyloxcard
infusion. But incessant VT continued and he was shifted to our
hospital by air ambulance. In spite of trying all pharmacological
therapy his VT continued.
So electrophysiological study was planned under CARTOmapping
systemwhich showed ventricular tachyarrhythmiawas automatic
in nature arising from left basal posterior region. Ablation was
performed at 40 W power and 458 temperature at and around the
area of VT origin. Post ablation VT was still inducible but its
frequency had come down signiﬁcantly and the rate was consid-
erably lower. The next day patient was found to have only PVC's
and subsequently he remained in sinus rhythm. His condition
further improved and he was discharged after 7 days. A follow
up after 3monthswithHolter report showed no PVC's or VT and 2D
echo also showed improved ejection fraction to 50%.
Discussion: The clinical spectrum of viral cardiomyopathy can be
classiﬁed as fulminant, acute, or chronic. Viremia is followed by
cardiomyocyte infection. The clinical presentation of viral myo-
carditis varies from nonspeciﬁc electrocardiographic abnormal-
ities and mild viral illness to acute hemodynamic compromise
or sudden cardiac death. The initial evaluation should include
electrocardiography, echocardiography, and often contrast-
enhanced cardiac MRI. Patients with presentations suggestive of
ischemia should usually undergo coronary angiography. Patients
with VT, hemodynamic instability, or high-grade atrioventricular
block should usually undergo endomyocardial biopsy. All patients
should receive standard heart failure care as outlined in the ACC/
AHA/ESC, andHeart Failure Society of America guidelines. Ongoing
trials of antiviral treatment such as the use of interferon beta may
lead to the use of speciﬁc antiviral treatment in the future.
Very few reports are available where successful transcatheter cure
of VT in myocariditis induced dilated cardiomyopathy are avail-
able. The VT and left ventricular dysfunction resolved with suc-
cessful radiofrequency ablation. incessant VT can cause reversible
left ventricular dysfunction. The diagnosis should be suspected in
patients who present with incessant tachycardia and apparent
idiopathic cardiomyopathy. Successful radiofrequency ablation
can resolve the tachycardia and the left ventricular dysfunction.
Conclusion: Suspected viral myocarditis is an important cause of
cardiomyopathy that presents diagnostic and therapeutic chal-
lenges. The initial evaluation should include electrocardiography,
echocardiography, and often contrast-enhanced cardiac MRI. The
indication for ablation in monomorphic ventricular premature
beats is considered exceptional. The recommendation for ablation
in repetitive VT is contemplated in patients with symptoms and
those who fail to respond to or cannot tolerate drug therapy;
tachycardia-induced cardiomyopathy is not mentioned. Consider-
ing that ablation in these tachycardia patients has a success rate of
nearly 80% and a complication rate similar to that of other more
common origins, the indication for this procedure should be
assessed when there is frequent monomorphic ventricular
arrhythmia (premature beats, whether isolated or associated with
repetitive tachycardia) together with apparently idiopathic left-
ventricular dysfunction.
A single center experience of electrical
VT storm
M. Sadiq Azam, T.N.C. Padmanabhan, P.A. Jiwani,
S.V. Srinath, B. BhaskarRao, R.K. Jain, B. Hygriv Rao
Krishna Institute of Medical Sciences, Hyderabad, India
Background: Electrical storm (ES) is a life-threatening emergency
with an incidence of 10–28% and in-hospital mortality of 60–70%.
We report a single center experience of 8 patients with ES.
Methods: All patients presenting with ES between January 2012
and August 2015 were prospectively enrolled. Clinical proﬁles and
in-hospital outcomes were tabulated. All those discharged were
followed up with review of device data logs.
Results: 8 patients (7 male and 1 female) presented with recurrent
ICD shocks (n = 4) or VT/VF (n = 4) (Table 1). Themean age and LVEF
of the cohort was 57.67  7.67 years and 34.79  4.17% respectively.
6 patients were electively mechanically ventilated and one addi-
tionally required IABP. All received amiodarone, lignocaine and
maximally tolerated dose of beta blockers. Phenytoin and mexiti-
line were given in 1 patient each. 1 patient was found to have
thyrotoxicosis and settled with anti-thyroid drugs. 2 patients
underwent stellate ganglionectomy and 7 patients underwent
VT ablation by 3D mapping. All patients had hemodynamically
unstable VTs of multiple morphologies (3.17  1.6). Strategies for
RFA included substrate modiﬁcation targeting abnormal electro-
grams in scar area (n = 8), isolation of LV aneurysm (n = 1) and
Table 1
Patient
#
Age
(years)
Sex LVEF
(%)
Presentation No of ICD
shocks in
a day
No of DC
shocks
delivered
in ICCU
Rx: RFA/
Stellate/
medical
only
Clinical
substrate
In-
hospital
outcome
Follow
up
(months)
ICD shock
and VT
episodes
1 61 M 30 Recurrent ICD
shocks
7 12 RFA ICM No VT 36 0-0
2 57 M 35 Recurrent VT – 22 RFA NICM No VT 30 0-0
3 65 M 25 Recurrent VT – 25 RFA ICM No VT 29 0-0
4 59 M 30 Recurrent ICD
shocks followed
by incessant VT
26 45 RFA + Stellate ICM No VT 24 0-0
5 54 M 35 Incessant VT/VF – 98 RFA + Stellate Early post
CABG
(4 weeks)
Expired N/A N/A
6 69 M 30 Recurrent VT – 30 RFA ICM No VT 8 0-0
7 46 F 35 Recurrent ICD
shocks
5 0 Medical ICM No VT 7 0-0
8 68 M 25 Recurrent ICD
shocks
4 0 RFA ICM No VT 4 0-0
ICM: ischemic cardiomyopathy; NICU: non-ischemic cardiomyopathy; RFA: radiofrequency ablation.
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